Mechanisms of Bone Metastasis
Top Cited Papers
- 15 April 2004
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (16) , 1655-1664
- https://doi.org/10.1056/nejmra030831
Abstract
One metastases are a frequent complication of cancer, occur- ring in up to 70 percent of patients with advanced breast or prostate cancer 1 and in approximately 15 to 30 percent of patients with carcinoma of the lung, colon, stomach, bladder, uterus, rectum, thyroid, or kidney. The exact incidence of bone metastasis is unknown, but it is estimated that 350,000 people die with bone metastases annually in the United States. 2 Furthermore, once tumors metastasize to bone, they are usually incurable: only 20 percent of patients with breast cancer are still alive five years after the discovery of bone metastasis. 3 The consequences of bone metastasis are often devastating. Osteolytic metastases can cause severe pain, pathologic fractures, life- threatening hypercalcemia, spinal cord compression, and other nerve-compression syn- dromes. Patients with osteoblastic metastases have bone pain and pathologic fractures because of the poor quality of bone produced by the osteoblasts. For all these reasons, bone metastasis is a serious and costly complication of cancer.Keywords
This publication has 81 references indexed in Scilit:
- Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the diseaseBlood, 2003
- The potential role of bisphosphonates in prostate cancerProstate Cancer and Prostatic Diseases, 2002
- The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastasesSeminars in Oncology, 2001
- Breast Cancer Cell Line MDA-231 Stimulates Osteoclastogenesis and Bone Resorption in Human OsteoclastsBiochemical and Biophysical Research Communications, 2000
- Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of BoneBiochemical and Biophysical Research Communications, 1998
- Cytokine Expression in Multiple Myeloma and Monoclonal Gammopathy: Analysis by Reverse Transcription/Polymerase Chain Reaction and Quantitative PCRLeukemia & Lymphoma, 1996
- An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cellsBiochemical and Biophysical Research Communications, 1990
- Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitroJournal of Bone and Mineral Research, 1989
- Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalaciaCancer, 1983
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889